Page 1

Consolidated Investment Analysis for Merck & Co Inc. Merck & Co Inc. (NYSE: MRK) Company Description Merck & Co., Inc. (Merck) is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of products to improve human and animal health. The Company's operations are principally managed on a products basis and consist of two business segments. The Pharmaceutical segment includes human health pharmaceutical products marketed either directly or through joint ventures. These products consist of therapeutic and preventive agents, sold by prescription, for the treatment of human disorders. The Vaccines and Infectious Diseases segment includes human health vaccine products marketed either directly or through a joint venture. These products consist of preventative pediatric, adolescent and adult vaccines, primarily administered at physician offices. Infectious disease products consist of therapeutic agents for the treatment of infection sold primarily to drug wholesalers and retailers, hospitals and government agencies. Share Statistics Symbol MRK Current Price 36.92 52wk Range 20.05- 41.56 Avg Vol (3m) 16,301,400

EPS Market Cap 52wk Change P/E (ttm)

3.81 77.87B 24.23% 9.70

Financial Summary On October 22, 2009, Merck & Co Inc reported 3rd quarter 2009 earnings of 0.90 per share. This result exceeded the 0.82 consensus of the 12 analysts covering the company and exceeded last year's 3rd quarter results by 12.50%. The next earnings announcement is expected on February 16, 2010. Merck & Co Inc reported annual 2008 earnings of 3.42 per share on February 03, 2009. The next earnings announcement from Merck & Co Inc is expected the week of February 16, 2010. MRK had 3rd quarter 2009 revenues of 6.05bn. This bettered the 5.99bn consensus of the 9 analysts covering the company. This was 2.54% above the prior year's 3rd quarter results. MRK had revenues for the full year 2008 of 23.85k. This was -1.44% below the prior year's results.


Analyst Consensus Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 19 polled investment analysts. Against the Merck & Co Inc company. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

9

5

5

0

0

0

4 weeks ago

9

5

5

0

0

0

2 months ago

9

4

6

0

0

0

3 months ago

8

4

6

0

0

0

Last year

4

2

10

0

1

0

The 15 analysts offering 12 month price targets for Merck & Co Inc (MRK:NYQ) have a median target of 43.00, with a high estimate of 73.00 and a low estimate of 33.99. The median estimate represents a 16.47% increase from the last price of 36.92.

# of Estimates

Mean

High

Low

1 Year Ago

SALES (in millions)

Quarter Ending Mar-10

6

11,026.10

11,714.00

10,462.00

--

Quarter Ending Jun-10

6

11,469.10

11,879.70

11,043.00

--

12

45,562.50

47,650.80

43,359.00

24,008.00

Quarter Ending Mar-10

7

0.82

0.86

0.75

0.77

Quarter Ending Jun-10

7

0.87

0.93

0.84

0.77

Year Ending Dec-10

17

3.45

3.57

3.37

3.48

LT Growth Rate (%)

11

6.16

18.00

1.75

3.35

Year Ending Dec-10

Earnings (per share)


Technical Analysis Chart

NET SHARE PURCHASE ACTIVITY

Insider Purchases - Last 6 Months Shares

Trans

Purchases

N/A

0

Sales

N/A

0

N/A

0

111.51M

N/A

0.0%

N/A

Net Shares Purchased (Sold) Total Insider Shares Held % Net Shares Purchased (Sold) Net Institutional Purchases - Prior Qtr to Latest Qtr

Shares Net Shares Purchased (Sold) % Change in Institutional Shares Held

204,503,000 24.1%


DIRECT COMPETITOR COMPARISON

MRK

BAYRY.PK

GSK

PFE

Industry

Market Cap:

77.87B

N/A

98.27B

143.64B

115.42M

Employ ees:

55,200

N/A

N/A

120,700

181

Qtrly Rev Growth (yoy):

1.80%

N/A

17.10%

33.90%

14.60%

Revenue (ttm):

23.37B

N/A

44.54B

50.01B

31.21M

Gross Margin (ttm):

76.36%

N/A

74.99%

82.52%

73.28%

7.81B

N/A

14.18B

19.91B

-1.59M

26.63%

N/A

27.37%

31.85%

18.18%

Net Income (ttm):

8.05B

N/A

8.68B

8.62B

N/A

EPS (ttm):

3.808

N/A

3.40

1.226

N/A

P/E (ttm):

9.70

N/A

11.40

14.52

11.40

PEG (5 yr expected):

2.47

2.24

1.88

5.66

1.88

P/S (ttm):

3.33

N/A

2.19

2.88

3.33

EBITDA (ttm): Oper Margins (ttm):


Consolidated Investment Analysis for Kraft Foods Inc. Kraft Foods Inc. (NYSE: KFT) Company Description Kraft Foods Inc. (Kraft) is engaged in manufacturing and marketing packaged food products, including snacks, beverages, cheese, convenient meals and various packaged grocery products. During the year ended December 31, 2008, the Company have operations in more than 70 countries and sell the products in approximately 150 countries. The Company manages and operates, through two commercial units: Kraft North America and Kraft International. Kraft North America operates in the United States and Canada. On August 4, 2008, the Company completed the spin-off of its post cereals business. The brands of the Company span five consumer sectors: snacks, beverages, cheese, grocery and convenient meals. In February 2010, the Company announced that it has acquired control of Cadbury plc. Share Statistics Symbol KFT Current Price 29.09 52wk Range 20.81- 30.10 Avg Vol (3m) 17,055,800

EPS Market Cap 52wk Change P/E (ttm)

1.69 42.93B 15.85% 17.16

Financial Summary On November 03, 2009, Kraft Foods Inc reported 3rd quarter 2009 earnings of 0.55 per share. This result exceeded the 0.49 consensus of the 11 analysts covering the company and exceeded last year's 3rd quarter results by 22.22%. The next earnings announcement is expected on February 16, 2010. Kraft Foods Inc reported annual 2008 earnings of 1.83 per share on February 04, 2009. The next earnings announcement from Kraft Foods Inc is expected the week of February 16, 2010. KFT had 3rd quarter 2009 revenues of 9.80bn. This missed the 10.31bn consensus estimate of the 9 analysts following the company. This was -3.53% below the prior year's 3rd quarter results. KFT had revenues for the full year 2008 of 42.20k. This was 13.32% above the prior year's results.


Analyst Consensus Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 15 polled investment analysts. Against the Kraft Foods Inc company. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

6

4

5

0

0

2

4 weeks ago

4

2

6

0

0

1

2 months ago

4

2

6

0

0

1

3 months ago

4

3

8

0

0

1

Last year

4

1

12

0

0

0

The 13 analysts offering 12 month price targets for Kraft Foods Inc (KFT:NYQ) have a median target of 33.00, with a high estimate of 37.00 and a low estimate of 27.00. The median estimate represents a 13.44% increase from the last price of 29.09.

# of Estimates

Mean

High

Low

1 Year Ago

SALES (in millions)

Quarter Ending Mar-10

3

10,790.00

10,987.00

10,646.00

10,353.00

Quarter Ending Jun-10

3

12,507.70

12,706.00

12,395.00

11,206.50

Year Ending Dec-10

6

49,219.50

50,211.00

48,465.00

43,155.10

Quarter Ending Mar-10

4

0.46

0.49

0.43

0.43

Quarter Ending Jun-10

4

0.54

0.58

0.52

0.60

Year Ending Dec-10

7

2.04

2.08

2.00

2.03

LT Growth Rate (%)

5

6.18

8.00

4.90

6.40

Earnings (per share)


Technical Analysis

NET SHARE PURCHASE ACTIVITY

Insider Purchases - Last 6 Months Shares

Trans

Purchases

N/A

0

Sales

N/A

0

N/A

0

138.34M

N/A

0.0%

N/A

Net Shares Purchased (Sold) Total Insider Shares Held % Net Shares Purchased (Sold) Net Institutional Purchases - Prior Qtr to Latest Qtr

Shares Net Shares Purchased (Sold) % Change in Institutional Shares Held

(45,484,000) (7.1%)


DIRECT COMPETITOR COMPARISON

KFT

CAG

NSRGY.PK

Pvt1

Industry

Market Cap:

42.93B

10.38B

N/A

N/A

1.62B

Employ ees:

98,000

25,600

N/A

N/A

32.40K

Qtrly Rev Growth (yoy):

-5.70%

-2.40%

N/A

N/A

8.40%

Revenue (ttm):

40.31B

12.56B

N/A

N/A

6.89B

Gross Margin (ttm):

34.85%

25.05%

N/A

N/A

34.85%

6.27B

1.67B

N/A

N/A

415.26M

13.41%

10.67%

N/A

N/A

15.28%

Net Income (ttm):

2.42B

777.40M

N/A

N/A

N/A

EPS (ttm):

1.695

1.726

N/A

N/A

1.69

P/E (ttm):

17.16

13.56

N/A

N/A

13.77

2.3

1.14

2.35

N/A

2.30

1.06

0.82

N/A

N/A

1.37

EBITDA (ttm): Oper Margins (ttm):

PEG (5 yr expected): P/S (ttm):


Consolidated Investment Analysis For Teva Pharmaceuticals Teva Pharmaceuticals (NASDAQ: TEVA) Company Description Teva Pharmaceutical Industries Limited (Teva) is a global pharmaceutical company that develops, produces and markets generic drugs covering all treatment categories. The Company has a pharmaceutical business, whose principal products are Copaxone for multiple sclerosis and Azilect for Parkinson's disease and respiratory products. Teva's active pharmaceutical ingredient business provides vertical integration to Teva's own pharmaceutical production and sells to third party manufacturers. The Company's global operations are conducted in North America, Europe, Latin America, Asia and Israel. Teva has operations in more than 60 countries, as well as 38 finished dosage pharmaceutical manufacturing sites in 17 countries, 20 generic research and development centers operating mostly within certain manufacturing sites and 20 API manufacturing sites around the world. In January 2009, Phibro Animal Health Corporation completed the acquisition of the Abic Animal Health business from the Company. Share Statistics Symbol Current Price 52wk Range Avg Vol (3m)

TEVA 58.86 42.67- 59.62 4,967,760

EPS Market Cap 52wk Change P/E (ttm)

1.09 51.86B 36.47% 53.85

Financial Summary On November 03, 2009, Teva Pharmaceutical Ind reported 3rd quarter 2009 earnings of 0.89 per share. This result was in line with the consensus of the 3 analysts following the company and exceeded last year's 3rd quarter results by 23.61%. The next earnings announcement is expected on February 16, 2010. Teva Pharmaceutical Ind reported annual 2008 earnings of 2.86 per share on February 17, 2009. The next earnings announcement from Teva Pharmaceutical Ind is expected the week of February 16, 2010. TEVA.TA had 3rd quarter 2009 revenues of 3.55bn. This missed the 3.65bn consensus estimate of the 2 analysts following the company. This was 4.41% above the prior year's 3rd quarter results. TEVA.TA had revenues for the full year 2008 of 11.09k. This was 17.83% above the prior year's results.


Analyst Consensus Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 7 polled investment analysts. Against the Teva Pharmaceutical Ind company. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

3

2

2

0

0

1

4 weeks ago

2

2

2

0

0

1

2 months ago

2

2

2

0

0

1

3 months ago

2

2

2

0

0

1

Last year

4

3

0

0

0

0

# of Estimates

Mean

High

Low

1 Year Ago

SALES (in millions)

Quarter Ending Mar-10

8

3,813.53

4,307.00

3,591.80

--

Quarter Ending Jun-10

8

3,917.00

4,486.00

3,686.50

--

21

16,043.20

18,429.00

15,306.30

16,497.00

Quarter Ending Mar-10

8

0.97

1.09

0.86

--

Quarter Ending Jun-10

8

1.08

1.13

1.03

--

Year Ending Dec-10

23

4.47

4.63

3.38

3.63

LT Growth Rate (%)

6

17.40

35.00

7.00

15.80

Year Ending Dec-10

Earnings (per share)


Technical Analysis Chart


DIRECT COMPETITOR COMPARISON

TEVA

Pvt1

Pvt2

WPI

Industry

Market Cap:

51.86B

N/A

N/A

4.04B

170.20M

Employ ees:

38,307

12,1741

1501

5,070

94

Qtrly Rev Growth (yoy):

24.90%

N/A

N/A

3.30%

20.50%

Revenue (ttm):

12.95B

943.60M1

200.00K1

2.65B

46.74M

Gross Margin (ttm):

55.30%

N/A

N/A

44.90%

55.30%

3.94B

N/A

N/A

642.17M

-6.50M

24.35%

N/A

N/A

17.41%

2.08%

953.00M

N/A

N/A

221.48M

N/A

EPS (ttm):

1.093

N/A

N/A

1.940

-0.17

P/E (ttm):

53.85

N/A

N/A

19.63

18.13

PEG (5 yr expected):

1.15

N/A

N/A

1.87

0.92

P/S (ttm):

3.97

N/A

N/A

1.52

4.57

EBITDA (ttm): Oper Margins (ttm): Net Income (ttm):


Consolidated Investment Analysis for Intel Corp. Intel Corp. (NASDAQ: INTC) Company Description Intel Corporation is a semiconductor chip maker. The Company is engaged in developing advanced integrated digital technology products, primarily integrated circuits, for industries, such as computing and communications. Its primary component-level products include microprocessors, chipsets, motherboards, wired and wireless connectivity. The Company offers products at various levels of integration, allowing its customers the capability to create computing and communications systems. As of December 27, 2008, the Company was mainly organized in two segments: Digital Enterprise Group (DEG) and Mobility Group (MG). During the fiscal year ended December 27, 2008 (fiscal 2008), the Company completed the divestiture of its NOR flash memory business. In July 2009, Intel Corporation completed the acquisition of Wind River Systems, Inc. Share Statistics

Symbol Current Price 52wk Range Avg Vol (3m)

INTC 20.43 12.05- 21.55 61,542,800

EPS Market Cap 52wk Change P/E (ttm)

0.77 112.81B 45.10% 26.40

Financial Summary On January 14, 2010, Intel Corp reported 4th quarter 2009 earnings of 0.55 per share. This result exceeded the 0.45 consensus of the 13 analysts covering the company and exceeded last year's 4th quarter results by 0.51. The next earnings announcement is expected on April 12, 2010. Intel Corp reported annual 2009 earnings of 1.17 per share on January 14, 2010. INTC.O had 4th quarter 2009 revenues of 10.57bn. This bettered the 10.16bn consensus of the 31 analysts covering the company. This was 12.57% above the prior year's 4th quarter results. INTC.O had revenues for the full year 2009 of 35.13k. This was -6.54% below the prior year's results.


Analyst Consensus Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 39 polled investment analysts. Against the Intel Corp company. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

19

10

8

1

1

1

4 weeks ago

20

10

8

1

1

1

2 months ago

18

10

10

1

1

1

3 months ago

17

9

11

1

1

2

Last year

13

7

12

1

1

0

The 33 analysts offering 12 month price targets for Intel Corp (INTC:NSQ) have a median target of 26.00, with a high estimate of 32.00 and a low estimate of 17.00. The median estimate represents a 27.26% increase from the last price of 20.43.

# of Estimates

Mean

High

Low

1 Year Ago

SALES (in millions)

Quarter Ending Mar-10

31

9,767.92

10,100.00

9,690.10

7,648.18

Quarter Ending Jun-10

30

9,611.41

10,050.00

9,300.00

7,605.83

Year Ending Dec-10

33

40,633.20

42,000.00

35,143.00

32,169.20

Year Ending Dec-11

30

43,246.50

45,500.00

40,414.00

35,263.50

Quarter Ending Mar-10

32

0.37

0.40

0.35

0.15

Quarter Ending Jun-10

31

0.36

0.41

0.31

0.15

Year Ending Dec-10

34

1.64

1.83

1.23

0.80

Year Ending Dec-11

31

1.79

2.07

1.45

1.01

LT Growth Rate (%)

10

11.30

17.00

5.00

11.17

Earnings (per share)


Technical Analysis

NET SHARE PURCHASE ACTIVITY

Insider Purchases - Last 6 Months Shares Purchases Sales Net Shares Purchased (Sold) Total Insider Shares Held % Net Shares Purchased (Sold)

Trans 10,000

1

120,000

1

(110,000)

2

353.63M

N/A

0.0%

N/A

Net Institutional Purchases - Prior Qtr to Latest Qtr Shares Net Shares Purchased (Sold) % Change in Institutional Shares Held

(101,297,000) (3.1%)


DIRECT COMPETITOR COMPARISON

INTC

AMD

Pvt1

TXN

Industry

Market Cap:

112.81B

5.55B

N/A

29.80B

1.75B

Employ ees:

79,800

13,395

N/A

N/A

2.11K

Qtrly Rev Growth (yoy):

28.50%

34.10%

N/A

20.60%

8.70%

Revenue (ttm):

35.13B

5.40B

N/A

10.43B

611.40M

Gross Margin (ttm):

55.69%

42.05%

N/A

47.94%

42.39%

EBITDA (ttm):

13.69B

612.33M

N/A

3.13B

22.82M

Oper Margins (ttm):

24.59%

-9.49%

N/A

21.13%

8.24%

Net Income (ttm):

4.37B

141.00M

N/A

1.47B

N/A

EPS (ttm):

0.774

0.204

N/A

1.158

0.09

P/E (ttm):

26.40

38.58

N/A

20.75

40.23

PEG (5 yr expected):

1.06

N/A

N/A

1.29

1.49

P/S (ttm):

3.15

1.02

N/A

2.83

2.75


Consolidated Investment Analysis for International Business Machines International Business Machines (NYSE: IBM)

Company Description International Business Machines Corporation (IBM), is an information technology (IT) company. The Company's major operations include Global Technology Services segment (GTS), Global Business Services segment (GBS), Software segment, Systems and Technology segment, and Global Financing segment. On April 3, 2008, IBM acquired 100% of Telelogic, AB. In July 2008, the Company acquired Platform Solutions, Inc. In December 2008, its internal global logistics operations were acquired by SNCF Transport and logistics division of Geodis. In July 2009, IBM acquired Ounce Labs, Inc., a privately held company based in Waltham, Massachusetts, whose software helps companies to reduce the risks and costs associated with security and compliance concerns. In August 2009, the Company announced the launch of its China Analytics Solution Center, part of a network of global centers. In January 2010, announced the completion of its acquisition of Lombardi, a software company. Share Statistics Symbol Current Price 52wk Range Avg Vol (3m)

IBM 124.00 82.85- 134.25 6,469,370

EPS Market Cap 52wk Change P/E (ttm)

10.01 162.44B 30.31% 12.39

Financial Summary On January 19, 2010, International Business Machines Corp reported 4th quarter 2009 earnings of 3.59 per share. This result was in line with the consensus of the 21 analysts following the company and exceeded last year's 4th quarter results by 9.45%. The next earnings announcement is expected on April 19, 2010. International Business Machines Corp reported annual 2009 earnings of 10.01 per share on January 19, 2010. IBM had 4th quarter 2009 revenues of 27.23bn. This bettered the 26.91bn consensus of the 18 analysts covering the company. This was 15.55% above the prior year's 4th quarter results. IBM had revenues for the full year 2009 of 95.76k. This was -7.60% below the prior year's results.


Analyst Consensus Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 22 polled investment analysts. Against the International Business Machines Corp company. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

9

5

8

0

0

1

4 weeks ago

8

5

9

0

0

1

2 months ago

8

4

9

0

0

1

3 months ago

8

4

9

0

0

1

Last year

9

6

4

1

0

0

The 17 analysts offering 12 month price targets for International Business Machines Corp (IBM:NYQ) have a median target of 145.00, with a high estimate of 155.00 and a low estimate of 128.00. The median estimate represents a 16.94% increase from the last price of 124.00.

# of Estimates

Mean

High

Low

1 Year Ago

SALES (in millions)

Quarter Ending Jun-10

13

24,265.40

24,825.00

23,778.80

24,987.10

Year Ending Dec-10

18

99,658.50

100,799.00

98,331.50

100,290.00

Year Ending Dec-11

15

103,658.00

105,668.00

101,060.00

100,567.00

Quarter Ending Jun-10

16

2.59

2.69

2.53

2.15

Year Ending Dec-10

22

11.11

11.25

11.00

9.77

Year Ending Dec-11

19

12.13

12.50

11.51

10.41

LT Growth Rate (%)

7

9.66

12.00

8.00

10.80

Earnings (per share)


Technical Analysis Chart

NET SHARE PURCHASE ACTIVITY

Insider Purchases - Last 6 Months Shares Purchases Sales Net Shares Purchased (Sold) Total Insider Shares Held % Net Shares Purchased (Sold)

Trans N/A

0

489,751

15

(489,751)

15

73.67M

N/A

(0.7%)

N/A

Net Institutional Purchases - Prior Qtr to Latest Qtr Shares Net Shares Purchased (Sold) % Change in Institutional Shares Held

9,373,160 1.2%


DIRECT COMPETITOR COMPARISON

IBM

ACN

HPQ

MSFT

Industry

Market Cap:

162.44B

25.61B

114.57B

244.96B

1.41B

Employ ees:

N/A

176,000

304,000

93,000

4.90K

0.80%

-11.20%

-7.90%

14.40%

8.10%

Revenue (ttm):

95.76B

22.45B

114.55B

58.69B

958.78M

Gross Margin (ttm):

45.72%

30.01%

23.59%

79.78%

38.98%

EBITDA (ttm):

23.16B

3.32B

15.80B

24.43B

187.68M

Oper Margins (ttm):

19.00%

12.59%

9.62%

37.64%

10.60%

Net Income (ttm):

13.43B

1.55B

7.66B

16.26B

N/A

EPS (ttm):

10.008

2.375

3.143

1.815

0.38

P/E (ttm):

12.39

17.05

15.42

15.39

20.14

PEG (5 yr expected):

1.12

1.1

1.13

1.22

1.44

P/S (ttm):

1.69

1.13

1.00

4.20

1.48

Qtrly Rev Growth (yoy):


Consolidated Investment Analysis For Olin Corp. Olin Corp. (NYSE: OLN) Company Description Olin Corporation is a manufacturer concentrated in two business segments: Chlor Alkali Products and Winchester. Chlor Alkali Products manufactures and sells chlorine and caustic soda, sodium hydrosulfite, hydrochloric acid, hydrogen, bleach products and potassium hydroxide. During the year ended December 31, 2008, the Chlor Alkali Products segment represents 72% of its sales. The Winchester products segment represents 28% of its 2008 sales. The Winchester products segment includes sporting ammunition, reloading components, small caliber military ammunition and components, and industrial cartridges. Its subsidiary, PCI Chemicals Canada Company/Societe PCI Chimie Canada, operates one chlor alkali facility in Becancour, Canada, which sells chlor alkali-related products within Canada and to the United States. The Company's another subsidiary, Winchester Australia Limited, loads and packs sporting and industrial ammunition in Australia. Share Statistics Symbol OLN Current Price 16.40 52wk Range 8.97- 18.40 Avg Vol (3m) 852,808

EPS Market Cap 52wk Change P/E (ttm)

1.73 1.29B 16.15% 9.46

Financial Summary On January 26, 2010, Olin Corp reported 4th quarter 2009 losses of -0.03 per share. This result exceeded the -0.10 consensus loss of the 4 analysts covering the companyand under-performed last year's 4th quarter results by -0.67. The next earnings announcement is expected on April 26, 2010. Olin Corp reported annual 2009 earnings of 0.97 per share on January 26, 2010. OLN had 4th quarter 2009 revenues of 350.90m. This bettered the 329.68m consensus of the 4 analysts covering the company. This was -11.61% below the prior year's 4th quarter results. OLN had revenues for the full year 2009 of 1.53k. This was -13.20% below the prior year's results.


Analyst Consensus Buy

Outperform

Hold

Underperform

Sell

No Opinion

This is the consensus forecast amongst 5 polled investment analysts. Against the Olin Corp company. Analyst Detail

Buy

Outperform

Hold

Underperform

Sell

No Opinion

Latest

3

1

1

0

0

0

4 weeks ago

3

1

1

0

0

0

2 months ago

3

1

1

0

0

0

3 months ago

3

1

1

0

0

0

Last year

3

0

2

0

0

0

The 5 analysts offering 12 month price targets for Olin Corp (OLN:NYQ) have a median target of 23.00, with a high estimate of 24.00 and a low estimate of 18.00. The median estimate represents a 40.24% increase from the last price of 16.40.

# of Estimates

Mean

High

Low

1 Year Ago

SALES (in millions)

Quarter Ending Mar-10

4

349.83

380.00

325.00

--

Quarter Ending Jun-10

4

385.67

410.00

361.00

--

Year Ending Dec-10

4

1,546.82

1,624.00

1,447.00

1,703.37

Year Ending Dec-11

3

1,638.80

1,681.00

1,600.00

1,763.80

Quarter Ending Mar-10

5

0.10

0.10

0.10

0.54

Quarter Ending Jun-10

5

0.21

0.30

0.13

0.50

Year Ending Dec-10

4

0.84

1.00

0.72

1.84

Year Ending Dec-11

3

1.21

1.27

1.15

1.51

LT Growth Rate (%)

1

24.00

24.00

24.00

6.50

Earnings (per share)


Technical Analysis Chart

NET SHARE PURCHASE ACTIVITY

Insider Purchases - Last 6 Months Shares Purchases Sales Net Shares Purchased (Sold) Total Insider Shares Held % Net Shares Purchased (Sold)

Trans N/A

0

6,000

1

(6,000)

1

270.72K

N/A

(2.2%)

N/A

Net Institutional Purchases - Prior Qtr to Latest Qtr Shares Net Shares Purchased (Sold) % Change in Institutional Shares Held

(14,514,900) (33.8%)


DIRECT COMPETITOR COMPARISON

OLN

ATK

DOW

Pvt1

Industry

Market Cap:

1.29B

2.54B

30.93B

N/A

214.71M

Employ ees:

N/A

19,000

52,000

2,5001

805

-19.20%

2.90%

14.40%

N/A

7.20%

1.53B

4.82B

44.88B

612.40M1

266.97M

20.16%

21.65%

13.23%

N/A

23.48%

247.80M

649.43M

4.26B

N/A

14.34M

11.50%

11.37%

3.47%

N/A

3.98%

135.70M

198.17M

226.00M

N/A

N/A

EPS (ttm):

1.733

5.946

0.319

N/A

0.09

P/E (ttm):

9.46

12.94

87.12

N/A

15.77

0.9

0.67

1.48

N/A

1.42

0.82

0.53

0.69

N/A

1.67

Qtrly Rev Growth (yoy): Revenue (ttm): Gross Margin (ttm): EBITDA (ttm): Oper Margins (ttm): Net Income (ttm):

PEG (5 yr expected): P/S (ttm):


Report Disclaimer DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS. We are not registered as a securities broker-dealer or an investment advisor either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them. Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment adviser or licensed stock broker before investing. This report is a service of Seo Freisin, Inc., a financial public relations firm that has been compensated by the companies profiled. All direct and third party compensation received has been disclosed on both, this newsletter, and on our website in accordance with section 17(b) of the Securities Act of 1933. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies. Seo Freisin, Inc., and/or its affiliates will hold, buy, and sell securities in the companies profiled. When compensated in shares, all readers should be aware that it is our policy to liquidate all shares immediately. We reserve the right to buy or sell the shares of any the companies mentioned in any materials we produce at any time. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies. ChartPoppers.com is a Web site wholly-owned by Seo Freisin, Inc. Seo Freisin, Inc., has not been compensated for any of the Companies mentioned in this report, we also do not own any shares in the companies discussed in this report. Information contained in our report will contain “forward looking statements” as defined under section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are


cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in this report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org


MRK, KFT, TEVA, INTC, IBM, OLN  

Consolidated Investment Analysis on MRK, KFT, TEVA, INTC, IBM, OLN

Advertisement
Read more
Read more
Similar to
Popular now
Just for you